Form CORRESP - Correspondence:
SEC Accession No. 0001104659-22-050904
Filing Date
2022-04-27
Accepted
2022-04-27 12:47:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 5700
2 GRAPHIC logo.jpg GRAPHIC 3787
  Complete submission text file 0001104659-22-050904.txt   12168
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)